fda warning letters compounded semaglutide october 2025 National Hispanic Medical Association | After GLP-1 drugs were banned, counterfeit versions continued to circulate — and still do today. Understanding the risks and Why the FDA Issued 30
Description
Over time, especially past the recommended use window, the cumulative risk increases
In combination with positive diet changes, and regular exercise, this can help with weight management
In 2022 , demand for Wegovy and Ozempic outpaced supply, creating shortages that lasted months and left patients without the medications they had started taking
10 GLP-1 clinics in Kissimmee are currently accepting new patients
Outcomes are
